AMP-activated protein kinase and muscle insulin resistance

Frontiers in Bioscience

Volumn 14, Issue 12, 2009, Pages 4658-4672

  Kraegen, Edward W ^a   Bruce, Clinton ^b   Hegarty, Bronwyn D ^a   Ye, Ji Ming ^a   Turner, Nigel ^a   Cooney, Gregory J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Baker Heart Research Unit   (Australia)

Author keywords

AMPK; Fatty acids; Glucose metabolism; In vivo physiology; Insulin resistance; Liver; Muscle; Obesity; Review; Type 2 diabetes

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID;

ANIMAL; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENZYME ACTIVATION; HUMANS; INSULIN RESISTANCE; LIPIDS; MUSCLE, SKELETAL;

EID: 63849273089     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3558     Document Type: Article

References (115)

1. Zimmet, P., K. G. Alberti & J. Shaw: Global and societal implications of the diabetes epidemic. Nature, 414, 782-7(2001) (Pubitemid 34000780)
2. Ruderman, N. B. & A. K. Saha: Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme A. Obesity, 14 Suppl 1, 25S-33S (2006)
3. Storlien, L. H., A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri & E. W. Kraegen: Influence of dietary fat composition on development of insulin resistance in rats. Diabetes, 40, 280-289(1991)
4. Hegarty, B. D., S. M. Furler, J. Ye, G. J. Cooney & E. W. Kraegen: The role of intramuscular lipid in insulin resistance. Acta Physiol Scand, 178, 373-83(2003) (Pubitemid 36960428)
5. Shulman, G. I.: Cellular mechanisms of insulin resistance. J Clin Invest, 106, 171-6(2000) (Pubitemid 30483118)
6. Randle, P. J., P. B. Garland, C. N. Hales & E. A. Newsholme: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, i, 785-789 (1963)
7. Kelley, D. E., B. H. Goodpaster & L. Storlien: Muscle triglyceride and insulin resistance. Annu Rev Nutr, 22, 325-46(2002) (Pubitemid 35221465)
8. Gan, S. K., K. Samaras, C. Thompson, E. W. Kraegen, A. Carr, D. Cooper & D. J. Chisholm: Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes, 51, 3163-3169(2002) (Pubitemid 35246961)
9. Boesch, C., J. Slotboom, H. Hoppeler & R. Kreis: In vivo determination of intra-myocellular lipids In human muscle by means of localized H-1-MR-Spectroscopy. Magn. Reson. Med., 37, 484-493(1997) (Pubitemid 27146825)
10. Itani, S. I., N. B. Ruderman, F. Schmieder & G. Boden: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes, 51, 2005-11(2002) (Pubitemid 34729001)
11. Ye, J. M., G. Frangioudakis, M. A. Iglesias, S. M. Furler, B. Ellis, N. Dzamko, G. J. Cooney & E. W. Kraegen: Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology, 143, 4527-35(2002) (Pubitemid 35397592)
12. Laybutt, D. R., D. J. Chisholm & E. W. Kraegen: Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats. Am J Physiol, 273, E1-9 (1997)
13. Kraegen, E. W., A. K. Saha, E. Preston, D. Wilks, A. J. Hoy, G. J. Cooney & N. B. Ruderman: Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats. Am J Physiol, 290, E471-9 (2006) (Pubitemid 43671693)
14. Steinberg, G. R.: Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle, 6, 888-94(2007) (Pubitemid 46658739)
15. Kim, J. K., J. J. Fillmore, M. J. Sunshine, B. Albrecht, T. Higashimori, D. W. Kim, Z. X. Liu, T. J. Soos, G. W. Cline, W. R. O'Brien, D. R. Littman & G. I. Shulman: PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest, 114, 823-7(2004) (Pubitemid 39578741)
16. Polkinghorne, E., Q. Lau, G. J. Cooney, E. W. Kraegen & M. E. Cleasby: Local activation of the I{kappa}K-NF{kappa}B pathway in muscle does not cause insulin resistance. Am J Physiol In Press (2008)
17. Ruderman, N. & M. Prentki: AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature Rev Drug Discovery, 3, 340-51(2004) (Pubitemid 38499761)
18. Hardie, D. G.: The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci, 117, 5479-87(2004) (Pubitemid 40012195)
19. Kahn, B. B., T. Alquier, D. Carling & D. G. Hardie: AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab, 1, 15-25(2005) (Pubitemid 43960587)
20. Steinberg, G. R. & S. B. Jørgensen: The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem 7, 519-26(2007)
21. Banerjee, R. R., S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, C. M. Steppan, R. S. Ahima, S. Obici, L. Rossetti & M. A. Lazar: Regulation of fasted blood glucose by resistin. Science, 303, 1195-8(2004) (Pubitemid 38233585)
22. Barazzoni, R., A. Bosutti, M. Stebel, M. R. Cattin, E. Roder, L. Visintin, L. Cattin, G. Biolo, M. Zanetti & G. Guarnieri: Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol 288, E228-35 (2005) (Pubitemid 40023812)
23. Saha, A. K., A. J. Schwarsin, R. Roduit, F. Masse, V. Kaushik, K. Tornheim, M. Prentki & N. B. Ruderman: Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem, 275, 24279-83(2000) (Pubitemid 30626516)
24. Trumble, G. E., M. A. Smith & W. W. Winder: Purification and characterization of rat skeletal muscle acetyl-CoA carboxylase. Eur J Biochem, 231, 192-8(1995)
25. Bruce, C. R., C. Brolin, N. Turner, M. E. Cleasby, F. R. van der Leij, G. J. Cooney & E. W. Kraegen: Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am J Physiol, 292, E1231-7 (2007) (Pubitemid 46536525)
26. McGarry, J. D., S. E. Mills, C. S. Long & D. W. Foster: Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J, 214, 21-8(1983) (Pubitemid 13070677)
27. Saggerson, E. D. & C. A. Carpenter: Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart. FEBS Lett, 129, 229-32(1981)
28. Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M. F. Hirshman, L. J. Goodyear & D. E. Moller: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest, 108, 1167-74(2001) (Pubitemid 32995375)
29. Park, H., V. K. Kaushik, S. Constant, M. Prentki, E. Przybytkowski, N. B. Ruderman & A. K. Saha: Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem, 277, 32571-7(2002) (Pubitemid 34984761)
30. Blázquez, C., M. J. Geelen, G. Velasco & M. Guzmán: The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett, 489, 149-53(2001) (Pubitemid 32126399)
31. Cacicedo, J. M., N. Yagihashi, J. F. Keaney, N. B. Ruderman & Y. Ido: AMPK inhibits fatty acidinduced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun, 324, 1204-9(2004) (Pubitemid 40292150)
32. Steinberg, G. R., A. C. Smith, B. J. Van Denderen, Z. Chen, S. Murthy, D. J. Campbell, G. J. Heigenhauser, D. J. Dyck & B. E. Kemp: AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab, 89, 4575-80(2004) (Pubitemid 39244472)
33. Chen, M. B., A. J. McAinch, S. L. Macaulay, L. A. Castelli, P. E. O'Brien, J. B. Dixon, D. Cameron-Smith, B. E. Kemp & G. R. Steinberg: Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab, 90, 3665-72(2005) (Pubitemid 41014341)
34. Steinberg, G. R., A. J. McAinch, M. B. Chen, P. E. O'Brien, J. B. Dixon, D. Cameron-Smith & B. E. Kemp: The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab, 91, 3592-7(2006) (Pubitemid 44402142)
35. Kelley, D. E., B. Goodpaster, R. R. Wing & J. A. Simoneau: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol, 277, E1130-41 (1999) (Pubitemid 30046009)
36. Bandyopadhyay, G. K., J. G. Yu, J. Ofrecio & J. M. Olefsky: Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes, 55, 2277-85(2006) (Pubitemid 44743625)
37. Kim, J. Y., R. C. Hickner, R. L. Cortright, G. L. Dohm & J. A. Houmard: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol, 279, E1039-44 (2000)
38. Zong, H., J. M. Ren, L. H. Young, M. Pypaert, J. Mu, M. J. Birnbaum & G. I. Shulman: AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA, 99, 15983-7(2002) (Pubitemid 35462735)
39. Zhou, M., B. Z. Lin, S. Coughlin, G. Vallega & P. F. Pilch: UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am J Physiol, 279, E622-9 (2000)
40. Krauss, S., C. Y. Zhang, L. Scorrano, L. T. Dalgaard, J. St-Pierre, S. T. Grey & B. B. Lowell: Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest, 112, 1831-42(2003) (Pubitemid 38063706)
41. Stavinoha, M. A., J. W. Rayspellicy, M. F. Essop, C. Graveleau, E. D. Abel, M. L. Hart-Sailors, H. J. Mersmann, M. S. Bray & M. E. Young: Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. Am J Physiol, 287, E888-95 (2004) (Pubitemid 39382924)
42. Yu, X., S. McCorkle, M. Wang, Y. Lee, J. Li, A. K. Saha, R. H. Unger & N. B. Ruderman: Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia, 47, 2012-21(2004) (Pubitemid 40110213)
43. Saha, A. K., P. R. Avilucea, J. M. Ye, M. M. Assifi, E. W. Kraegen & N. B. Ruderman: Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun, 314, 580-5(2004) (Pubitemid 38084758)
44. Kelly, M., C. Keller, P. R. Avilucea, P. Keller, Z. Luo, X. Xiang, M. Giralt, J. Hidalgo, A. K. Saha, B. K. Pedersen & N. B. Ruderman: AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun, 320, 449-54(2004) (Pubitemid 38798888)
45. Wallenius, K., J. O. Jansson & V. Wallenius: The therapeutic potential of interleukin-6 in treating obesity. Expert opinion on biological therapy, 3, 1061-70(2003) (Pubitemid 37295762)
46. Liu, Y., Q. Wan, Q. Guan, L. Gao & J. Zhao: High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem Biophys Res Commun, 339, 701-7(2006) (Pubitemid 41739724)
47. Viollet, B., F. Andreelli, S. B. Jørgensen, C. Perrin, A. Geloen, D. Flamez, J. Mu, C. Lenzner, O. Baud, M. Bennoun, E. Gomas, G. Nicolas, J. F. Wojtaszewski, A. Kahn, D. Carling, F. C. Schuit, M. J. Birnbaum, E. A. Richter, R. Burcelin & S. Vaulont: The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest, 111, 91-8(2003) (Pubitemid 36134852)
48. Mu, J., J. T. Brozinick, O. Valladares, M. Bucan & M. J. Birnbaum: A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell, 7, 1085-94(2001) (Pubitemid 32525754)
49. Taylor, E. B., W. J. Ellingson, J. D. Lamb, D. G. Chesser & W. W. Winder: Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am J Physiol, 288, E1055-61 (2005) (Pubitemid 40726790)
50. Wu, Y., P. Song, J. Xu, M. Zhang & M. H. Zou: Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem, 282, 9777-88(2007) (Pubitemid 47104626)
51. Oakes, N. D., S. Camilleri, S. M. Furler, D. J. Chisholm & E. W. Kraegen: The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metab Clin Exp, 46, 935-42(1997) (Pubitemid 27339920)
52. Ye, J. M., N. Dzamko, A. J. Hoy, M. A. Iglesias, B. Kemp & E. Kraegen: Rosiglitazone treatment enhances acute AMP-activated protein kinasemediated muscle and adipose tissue glucose uptake in high-fat-fed rats. Diabetes, 55, 2797-804(2006) (Pubitemid 44923679)
53. Qiang, W., K. Weiqiang, Z. Qing, Z. Pengju & L. Yi: Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Exp Mol Med, 39, 535-43(2007) (Pubitemid 47443868)
54. Reznick, R. M., H. Zong, J. Li, K. Morino, I. K. Moore, H. J. Yu, Z. X. Liu, J. Dong, K. J. Mustard, S. A. Hawley, D. Befroy, M. Pypaert, D. G. Hardie, L. H. Young & G. I. Shulman: Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab, 5, 151-6(2007) (Pubitemid 46172924)
55. Bruce, C. R., V. A. Mertz, G. J. Heigenhauser & D. J. Dyck: The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes, 54, 3154-60(2005) (Pubitemid 43334369)
56. Sriwijitkamol, A., D. K. Coletta, E. Wajcberg, G. B. Balbontin, S. M. Reyna, J. Barrientes, P. A. Eagan, C. P. Jenkinson, E. Cersosimo, R. A. De Fronzo, K. Sakamoto & N. Musi: Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and doseresponse study. Diabetes, 56, 836-48(2007) (Pubitemid 46348486)
57. Musi, N., N. Fujii, M. F. Hirshman, I. Ekberg, S. Fröberg, O. Ljungqvist, A. Thorell & L. J. Goodyear: AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes, 50, 921-7(2001) (Pubitemid 32374520)
58. Koistinen, H. A., D. Galuska, A. V. Chibalin, J. Yang, J. R. Zierath, G. D. Holman & H. Wallberg-Henriksson: 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes, 52, 1066-72(2003) (Pubitemid 36523338)
59. Højlund, K., K. J. Mustard, P. Staehr, D. G. Hardie, H. Beck-Nielsen, E. A. Richter & J. F. Wojtaszewski: AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol, 286, E239-44 (2004) (Pubitemid 38140315)
60. Kawaguchi, T., K. Osatomi, H. Yamashita, T. Kabashima & K. Uyeda: Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive elementbinding protein by AMP-activated protein kinase. J Biol Chem, 277, 3829-35(2002) (Pubitemid 34968632)
61. Winder, W. W. & D. G. Hardie: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol, 277, E1-10 (1999) (Pubitemid 29356721)
62. Hayashi, T., M. F. Hirshman, E. J. Kurth, W. W. Winder & L. J. Goodyear: Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes, 47, 1369-73(1998) (Pubitemid 28357021)
63. Fujii, N., T. Hayashi, M. F. Hirshman, J. T. Smith, S. A. Habinowski, L. Kaijser, J. Mu, O. Ljungqvist, M. J. Birnbaum, L. A. Witters, A. Thorell & L. J. Goodyear: Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun, 273, 1150-5(2000) (Pubitemid 30481094)
64. Wojtaszewski, J. F., P. Nielsen, B. F. Hansen, E. A. Richter & B. Kiens: Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol (Lond), 528 Pt 1, 221-6(2000)
65. Wojtaszewski, J. F., M. Mourtzakis, T. Hillig, B. Saltin & H. Pilegaard: Dissociation of AMPK activity and ACCbeta phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun, 298, 309-16(2002) (Pubitemid 35333706)
66. Yu, M., N. K. Stepto, A. V. Chibalin, L. G. Fryer, D. Carling, A. Krook, J. A. Hawley & J. R. Zierath: Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (Lond), 546, 327-35(2003) (Pubitemid 36175971)
67. Chen, Z. P., G. K. McConell, B. J. Michell, R. J. Snow, B. J. Canny & B. E. Kemp: AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol 279, E1202-6 (2000)
68. Sano, H., S. Kane, E. Sano, C. P. Mîinea, J. M. Asara, W. S. Lane, C. W. Garner & G. E. Lienhard: Insulin-stimulated phosphorylation of a Rab GTPaseactivating protein regulates GLUT4 translocation. J Biol Chem, 278, 14599-602(2003) (Pubitemid 36799780)
69. Treebak, J. T., J. B. Birk, A. J. Rose, B. Kiens, E. A. Richter & J. F. Wojtaszewski: AS160 phosphorylation is associated with activation of alpha2beta2gamma1-but not alpha2beta2gamma3-AMPK trimeric complex in skeletal muscle during exercise in humans. Am J Physiol 292, E715-22 (2007)
70. Cuthbertson, D. J., J. A. Babraj, K. J. Mustard, M. C. Towler, K. A. Green, H. Wackerhage, G. P. Leese, K. Baar, M. Thomason-Hughes, C. Sutherland, D. G. Hardie & M. J. Rennie: 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes, 56, 2078-84(2007) (Pubitemid 47195820)
71. Minokoshi, Y., Y. B. Kim, O. D. Peroni, L. G. Fryer, C. Müller, D. Carling & B. B. Kahn: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 415, 339-43(2002) (Pubitemid 34087557)
72. Steinberg, G. R., M. L. Parolin, G. J. Heigenhauser & D. J. Dyck: Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol 283, E187-92 (2002) (Pubitemid 34686685)
73. Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B. B. Kahn & T. Kadowaki: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 8, 1288-95(2002) (Pubitemid 35373562)
74. Petersen, K. F., E. A. Oral, S. Dufour, D. Befroy, C. Ariyan, C. Yu, G. W. Cline, A. M. De Paoli, S. I. Taylor, P. Gorden & G. I. Shulman: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest, 109, 1345-50(2002) (Pubitemid 34546899)
75. Lönnqvist, F., L. Nordfors, M. Jansson, A. Thörne, M. Schalling & P. Arner: Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest, 99, 2398-404(1997) (Pubitemid 27227717)
76. Arita, Y., S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi & Y. Matsuzawa: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 257, 79-83(1999) (Pubitemid 29299050)
77. Kern, P. A., G. B. Di Gregorio, T. Lu, N. Rassouli & G. Ranganathan: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes, 52, 1779-85(2003) (Pubitemid 36792470)
78. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M. L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel & T. Kadowaki: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 7, 941-6(2001) (Pubitemid 32756432)
79. Xu, A., Y. Wang, H. Keshaw, L. Y. Xu, K. S. Lam & G. J. Cooper: The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest, 112, 91-100(2003) (Pubitemid 38056380)
80. Fruebis, J., T. S. Tsao, S. Javorschi, D. Ebbets-Reed, M. R. Erickson, F. T. Yen, B. E. Bihain & H. F. Lodish: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA, 98, 2005-10(2001) (Pubitemid 32165613)
81. Pischon, T., C. J. Girman, G. S. Hotamisligil, N. Rifai, F. B. Hu & E. B. Rimm: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 291, 1730-7(2004) (Pubitemid 38489895)
82. Kadowaki, T. & T. Yamauchi: Adiponectin and adiponectin receptors. Endocr Rev, 26, 439-51(2005) (Pubitemid 40686653)
83. Haffner, S. M.: Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol, 92, 18J-26J (2003)
84. Steensberg, A., C. Keller, R. L. Starkie, T. Osada, M. A. Febbraio & B. K. Pedersen: IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol 283, E1272-8 (2002) (Pubitemid 35340635)
85. Steensberg, A., C. P. Fischer, M. Sacchetti, C. Keller, T. Osada, P. Schjerling, G. van Hall, M. A. Febbraio & B. K. Pedersen: Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol (Lond), 548, 631-8(2003) (Pubitemid 36527483)
86. Glund, S., A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath & A. Krook: Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes, 56, 1630-7(2007) (Pubitemid 46842596)
87. van Hall, G., A. Steensberg, M. Sacchetti, C. Fischer, C. Keller, P. Schjerling, N. Hiscock, K. Møller, B. Saltin, M. A. Febbraio & B. K. Pedersen: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab, 88, 3005-10(2003) (Pubitemid 36877463)
88. Al-Khalili, L., K. Bouzakri, S. Glund, F. Lönnqvist, H. A. Koistinen & A. Krook: Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol, 20, 3364-75(2006) (Pubitemid 44833576)
89. Wallenius, V., K. Wallenius, B. Ahrén, M. Rudling, H. Carlsten, S. L. Dickson, C. Ohlsson & J. O. Jansson: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med, 8, 75-9(2002) (Pubitemid 34101732)
90. Iglesias, M. A., J. M. Ye, G. Frangioudakis, A. K. Saha, E. Tomas, N. B. Ruderman, G. J. Cooney & E. W. Kraegen: AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes, 51, 2886-94(2002)
91. Ju, J. S., M. A. Gitcho, C. A. Casmaer, P. B. Patil, D. G. Han, S. A. Spencer & J. S. Fisher: Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase. Am J Physiol, 292, C564-72 (2007) (Pubitemid 46115164)
92. Fisher, J. S., J. Gao, D. H. Han, J. O. Holloszy & L. A. Nolte: Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol 282, E18-23 (2002) (Pubitemid 34654101)
93. Musi, N., M. F. Hirshman, J. Nygren, M. Svanfeldt, P. Bavenholm, O. Rooyackers, G. Zhou, J. M. Williamson, O. Ljunqvist, S. Efendic, D. E. Moller, A. Thorell & L. J. Goodyear: Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes, 51, 2074-81(2002) (Pubitemid 34729010)
94. Fryer, L. G., A. Parbu-Patel & D. Carling: The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem, 277, 25226-32(2002) (Pubitemid 34951829)
95. Cleasby, M. E., N. Dzamko, B. D. Hegarty, G. J. Cooney, E. W. Kraegen & J. M. Ye: Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes, 53, 3258-66(2004) (Pubitemid 39564503)
96. Hundal, R. S., M. Krssak, S. Dufour, D. Laurent, V. Lebon, V. Chandramouli, S. E. Inzucchi, W. C. Schumann, K. F. Petersen, B. R. Landau & G. I. Shulman: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes, 49, 2063-9(2000)
97. Owen, M. R., E. Doran & A. P. Halestrap: Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J, 348 Pt 3, 607-14(2000) (Pubitemid 30410251)
98. Zang, M., A. Zuccollo, X. Hou, D. Nagata, K. Walsh, H. Herscovitz, P. Brecher, N. B. Ruderman & R. A. Cohen: AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem, 279, 47898-905(2004) (Pubitemid 39540941)
99. Nawrocki, A. R., M. W. Rajala, E. Tomas, U. B. Pajvani, A. K. Saha, M. E. Trumbauer, Z. Pang, A. S. Chen, N. B. Ruderman, H. Chen, L. Rossetti & P. E. Scherer: Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem, 281, 2654-60(2006) (Pubitemid 43845727)
100. LeBrasseur, N. K., M. Kelly, T. S. Tsao, S. R. Farmer, A. K. Saha, N. B. Ruderman & E. Tomas: Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol, 291, E175-81 (2006) (Pubitemid 44035323)
101. Lee, Y. S., W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J. M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, C. Hohnen-Behrens, A. Gosby, E. W. Kraegen, D. E. James & J. B. Kim: Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes, 55, 2256-64(2006) (Pubitemid 44743622)
102. Cheng, Z., T. Pang, M. Gu, A. H. Gao, C. M. Xie, J. Y. Li, F. J. Nan & J. Li: Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta, 1760, 1682-9(2006) (Pubitemid 44667275)
103. Yin, J., Z. Gao, D. Liu, Z. Liu & J. Ye: Berberine Improves Glucose Metabolism through Induction of Glycolysis. Am J Physiol (2007)
104. Turner, N., J. Y. Li, A. Gosby, S. W. To, Z. Cheng, H. Miyoshi, M. M. Taketo, G. J. Cooney, E. W. Kraegen, D. E. James, L. H. Hu, J. Li & J. M. Ye: Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes, 57, 1414-8(2008)
105. Tan, M. J., J. M. Ye, N. Turner, C. Hohnen-Behrens, C. Q. Ke, C. P. Tang, T. Chen, H. C. Weiss, E. R. Gesing, A. Rowland, D. E. James & Y. Ye: Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol, 15, 263-73(2008) (Pubitemid 351381992)
106. Vaillancourt, V. A., S. D. Larsen, S. P. Tanis, J. E. Burr, M. A. Connell, M. M. Cudahy, B. R. Evans, P. V. Fisher, P. D. May, M. D. Meglasson, D. D. Robinson, F. C. Stevens, J. A. Tucker, T. J. Vidmar & J. H. Yu: Synthesis and biological activity of aminoguanidine and diaminoguanidine analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid. J Med Chem, 44, 1231-48(2001) (Pubitemid 32861758)
107. Cool, B., B. Zinker, W. Chiou, L. Kifle, N. Cao, M. Perham, R. Dickinson, A. Adler, G. Gagne, R. Iyengar, G. Zhao, K. Marsh, P. Kym, P. Jung, H. S. Camp & E. Frevert: Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab, 3, 403-16(2006) (Pubitemid 43811782)
108. Zhao, G., R. R. Iyengar, A. S. Judd, B. Cool, W. Chiou, L. Kifle, E. Frevert, H. Sham & P. R. Kym: Discovery and SAR development of thienopyridones: a class of small molecule AMPK activators. Bioorg Med Chem Lett, 17, 3254-7(2007) (Pubitemid 46819044)
109. Koves, T. R., J. R. Ussher, R. C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J. R. Dyck, C. B. Newgard, G. D. Lopaschuk & D. M. Muoio: Mitochondrial overload and incomplete Fatty Acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab, 7, 45-56(2008)
110. Abu-Elheiga, L., W. Oh, P. Kordari & S. J. Wakil: Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA, 100, 10207-12(2003) (Pubitemid 37071857)
111. Choi, C. S., D. B. Savage, L. Abu-Elheiga, Z. X. Liu, S. Kim, A. Kulkarni, A. Distefano, Y. J. Hwang, R. M. Reznick, R. Codella, D. Zhang, G. W. Cline, S. J. Wakil & G. I. Shulman: Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA, 104, 16480-5(2007) (Pubitemid 350211044)
112. Harwood, H. J., S. F. Petras, L. D. Shelly, L. M. Zaccaro, D. A. Perry, M. R. Makowski, D. M. Hargrove, K. A. Martin, W. R. Tracey, J. G. Chapman, W. P. Magee, D. K. Dalvie, V. F. Soliman, W. H. Martin, C. J. Mularski & S. A. Eisenbeis: Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem, 278, 37099-111(2003) (Pubitemid 37175224)
113. An, J., D. M. Muoio, M. Shiota, Y. Fujimoto, G. W. Cline, G. I. Shulman, T. R. Koves, R. Stevens, D. Millington & C. B. Newgard: Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med, 10, 268-74(2004) (Pubitemid 38667617)
114. Foretz, M., N. Ancellin, F. Andreelli, Y. Saintillan, P. Grondin, A. Kahn, B. Thorens, S. Vaulont & B. Viollet: Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes, 54, 1331-9(2005) (Pubitemid 40586661)
115. Savage, D. B., C. S. Choi, V. T. Samuel, Z. X. Liu, D. Zhang, A. Wang, X. M. Zhang, G. W. Cline, X. X. Yu, J. G. Geisler, S. Bhanot, B. P. Monia & G. I. Shulman: Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest, 116, 817-24(2006) (Pubitemid 43326891)